Review human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing (Q40479366)

20 September 2017

1 reference

reason for preferred rank

title

Review human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

3 August 2024

Human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669929

3 August 2024

1 reference

1

C. S. Herrington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669929

3 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7669929

3 August 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2303.1995.tb00471.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2303.1995.tb00471.x

3 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

3 August 2024

1 reference

20 September 2017

volume

6

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

176-189

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

20 September 2017

1 reference

The human papillomavirus E7 protein as a transforming and transactivating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Specific rearrangements of human papillomavirus DNA provide molecular evidence for genetic heterogeneity of primary cervical cancers, recurrencies, and lymph node metastases in two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

The discrimination of high-risk HPV types by in situ hybridization and the polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

HPV16 DNA and prediction of high-grade CIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Papillomaviruses, p53, and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Localization of p53 protein and human papillomavirus in anogenital squamous lesions: immunohistochemical and in situ hybridization studies in benign, dysplastic, and malignant epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Human papillomavirus type 16 alters human epithelial cell differentiation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

The chromosomal analysis of human solid tumors. A triple challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1995.TB00471.X

Risk Factors Associated with Cervical Human Papillomavirus Infections: A Case-Control Study

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Taxonomy of the human papillomaviruses

3 August 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations

3 August 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes

3 August 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Natural history and epidemiological features of genital HPV infection

3 August 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation

3 August 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Discrimination of closely homologous HPV types by nonisotopicin situ hybridization: definition and derivation of tissue melting temperatures

3 August 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Discrimination of closely homologous human genomic and viral sequences in cells and tissues: further characterization of Tmt

3 August 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Detection of high risk human papillomavirus in routine cervical smears: strategy for screening.

3 August 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines

3 August 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomavirus detection by hybrid capture and its possible clinical use.

3 August 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]

3 August 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Absence of human papillomavirus type 16 E6 transcripts in HPV 16-infected, cytologically normal cervical scrapings

3 August 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Simultaneous in situ genotyping and phenotyping of human papillomavirus cervical lesions: comparative sensitivity and specificity

3 August 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours

3 August 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm

3 August 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix

3 August 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomavirus type-16-related DNA in genital Bowen's disease and in bowenoid papulosis

3 August 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo

3 August 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa.

3 August 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions

3 August 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

3 August 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening

3 August 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

3 August 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

3 August 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

p53 point mutation in HPV negative human cervical carcinoma cell lines

3 August 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Genetic alterations of the TP53 gene, p53 protein expression and hpv infection in primary cervical carcinomas

3 August 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix

3 August 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

3 August 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression

3 August 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Cytogenetic findings in cervical carcinoma. A statistical approach

3 August 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells

3 August 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones

3 August 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality

3 August 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Invasive cervical cancer and smoking in Latin America

3 August 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Damage to DNA in cervical epithelium related to smoking tobacco

3 August 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix

3 August 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression

3 August 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis

3 August 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Interactions between human papillomavirus and human immunodeficiency virus infections

3 August 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

High Frequency of Latent and Clinical Human Papillomavirus Cervical Infections in Immunocompromised Human Immunodeficiency Virus-Infected Women

3 August 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Langerhans'cells in human cervical epithelium: an immunohistological study

3 August 2024

91

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Langerhans'cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia

3 August 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA

3 August 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

Polymerase chain reaction detection of human papillomavirus: quantitation may improve clinical utility

3 August 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1365-2303.1995.TB00471.X

3 August 2024

Identifiers

1 reference

20 September 2017

1 reference